Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 6/20 | 0.59 |
| ▸ | CNR1 | P21554 | 5/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | CTSD | P07339 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17509546 | 0.96 | GAA (0.59) | CNR2CNR1CYP2C9GAATDP1 | |
| SCHEMBL4340803 | 0.91 | CNR1 (0.57) | CNR2CNR1CYP2C9GAATDP1 | |
| SCHEMBL10935027 | 0.88 | ALDH1A1 (0.52) | CNR2CNR1TDP1LMNAALDH1A1 | |
| SCHEMBL17502715 | 0.86 | NCEH1 (0.58) | CNR2CNR1CYP2C9GAATDP1 | |
| SCHEMBL27777554 | 0.85 | HTR1B (0.59) | CNR2CNR1GAATDP1L3MBTL1 | |
| SCHEMBL503962 | 0.85 | ALDH1A1 (0.61) | L3MBTL1LMNAALDH1A1TSHRRAB9A | |
| SCHEMBL30393029 | 0.85 | ALDH1A1 (0.61) | L3MBTL1LMNAALDH1A1TSHRRAB9A | |
| SCHEMBL17502757 | 0.85 | CNR2 (0.57) | CNR2CNR1CYP2C9GAATDP1 | |
| SCHEMBL17502613 | 0.85 | CNR2 (0.57) | CNR2CNR1CYP2C9GAATDP1 | |
| SCHEMBL17502626 | 0.85 | CNR2 (0.57) | CNR2CNR1CYP2C9GAATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0345869-A2 | Thermotropic copolyester and process for preparing it and use thereof | ENIRICERCHE S.p.A. (IT) | 1989-12-13 | — | — | EP | claimed |
| JP-60064891-A | — | — | None | — | — | JP | disclosed |
| JP-62059084-A | — | — | None | — | — | JP | disclosed |
| JP-62113589-A | — | — | None | — | — | JP | disclosed |
| US-8022072-B2 | Azolylmethylidenehydrazine derivative and use thereof | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 2011-09-20 | — | — | US | disclosed |
| US-20100190754-A1 | AZOLYLMETHYLIDENEHYDRAZINE DERIVATIVE AND USE THEREOF | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 2010-07-29 | — | — | US | disclosed |
| CN-101778828-A | Azolylmethylenehydrazine derivatives and uses thereof | KAKEN PHARMA CO LTD | 2010-07-14 | — | — | CN | disclosed |
| EP-2168951-A1 | AZOLYLMETHYLENEHYDRAZINE DERIVATIVE AND USE THEREOF | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 2010-03-31 | — | — | EP | disclosed |
| US-5326848-A | Thermotropic liquid crystal polyester | KURARAY CO., LTD. (JP) | 1994-07-05 | — | — | US | disclosed |
| EP-0345869-A2 | Thermotropic copolyester and process for preparing it and use thereof | ENIRICERCHE S.p.A. (IT) | 1989-12-13 | — | — | EP | disclosed |
| JP-S62113589-A | THERMAL RECORDING MATERIAL | RICOH CO LTD | 1987-05-25 | — | — | JP | disclosed |
| JP-S6259084-A | THERMAL RECORDING MATERIAL | RICOH CO LTD | 1987-03-14 | — | — | JP | disclosed |
| JP-S6064891-A | THERMOSENSITIVE RECORDING MATERIAL | RICOH CO LTD | 1985-04-13 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190754-A1 | AZOLYLMETHYLIDENEHYDRAZINE DERIVATIVE AND USE THEREOF | ARSA, AHR, HRH2 | CNR2 31/4885CNR1 67/4885CYP2C9 381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.